Page last updated: 2024-11-05

2,6-dichlorobenzamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID16183
CHEMBL ID3184754
CHEBI ID28435
SCHEMBL ID320037
MeSH IDM0160772

Synonyms (45)

Synonym
benzamide, 2,6-dichloro-
nsc53137
benzamide,6-dichloro-
nsc-53137
AC-907/25014155
2,6-dichlorobenzamide ,
2008-58-4
inchi=1/c7h5cl2no/c8-4-2-1-3-5(9)6(4)7(10)11/h1-3h,(h2,10,11
BAM ,
2,6-dichlorobenzoic acid amide
2,6-bam
CHEBI:28435 ,
einecs 217-918-4
hsdb 2728
nsc 53137
unii-e9jwf529eb
e9jwf529eb ,
cas-2008-58-4
tox21_301922
dtxsid7022170 ,
NCGC00255282-01
dtxcid502170
A814228
FT-0610595
PS-4563
AKOS009139303
SCHEMBL320037
dichlorobenzamide, 2,6-
2,6-dichlorobenzamide [hsdb]
CHEMBL3184754
mfcd00007975
2,6-dichlorobenzamide, pestanal(r), analytical standard
2,6-bam; bam; nsc 53137
2,6-dichlorobenzamide 100 microg/ml in acetonitrile
2,6-dichlorobenzamide 10 microg/ml in acetonitrile
J-013002
dichlobenil metabolite
dichlobenil tp1
ae c653711
ae c653711 (2,6-dichlorbenzamid)
CS-0204492
1219804-28-0
Q27103696
AMY3591
2,6-dichlorobenzamide--d3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
herbicideA substance used to destroy plant pests.
marine xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound in marine macro- and microorganisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
benzamides
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency24.33650.001022.650876.6163AID1224838; AID1224893
pregnane X nuclear receptorHomo sapiens (human)Potency0.06110.005428.02631,258.9301AID1346982
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (49)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (22.45)29.6817
2010's33 (67.35)24.3611
2020's5 (10.20)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.87 (24.57)
Research Supply Index3.91 (2.92)
Research Growth Index5.74 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (6.12%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (93.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]